SecSonar.com

Lisata Therapeutics, Inc. (LSTA)

Lisata Therapeutics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Lisata Therapeutics, Inc. (LSTA) is a Biotechnology company based in US with a market capitalization of $28.8M. Free cash flow was negative at -$16M. This page tracks LSTA's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 26 employees · IPO Mar 1, 1999

Valuation

Valuation & price

$3.17 · as of May 17, 2026 · -37.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.94

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$5.03$3.46$1.90Jul 25Dec 25Jul 26Jul 7, 25$2.48Jul 9, 25$2.93Jul 11, 25$2.71Jul 15, 25$2.70Jul 17, 25$2.41Jul 21, 25$2.58Jul 23, 25$2.65Jul 25, 25$2.69Jul 29, 25$2.57Jul 31, 25$2.48Aug 4, 25$2.57Aug 6, 25$2.96Aug 11, 25$2.77Aug 13, 25$2.66Aug 15, 25$2.53Aug 19, 25$2.50Aug 21, 25$2.47Aug 25, 25$2.53Aug 27, 25$2.50Aug 29, 25$2.32Sep 3, 25$2.30Sep 5, 25$2.17Sep 9, 25$2.20Sep 11, 25$2.24Sep 16, 25$2.30Sep 18, 25$2.39Sep 22, 25$2.29Sep 24, 25$2.35Sep 26, 25$2.47Sep 30, 25$2.62Oct 2, 25$2.55Oct 6, 25$2.51Oct 8, 25$2.53Oct 10, 25$2.37Oct 14, 25$2.42Oct 16, 25$2.52Oct 21, 25$2.40Oct 23, 25$2.35Oct 27, 25$2.80Oct 29, 25$2.66Oct 31, 25$2.79Nov 4, 25$2.47Nov 6, 25$2.35Nov 10, 25$2.10Nov 12, 25$2.16Nov 14, 25$2.12Nov 18, 25$2.05Nov 20, 25$1.99Nov 25, 25$2.06Nov 28, 25$2.06Dec 2, 25$1.90Dec 4, 25$2.03Dec 8, 25$1.95Dec 10, 25$2.06Dec 12, 25$2.00Dec 16, 25$2.05Dec 18, 25$2.01Dec 22, 25$2.07Dec 24, 25$2.05Dec 29, 25$1.95Jan 2, 26$1.96Jan 6, 26$1.95Jan 8, 26$2.06Jan 12, 26$2.08Jan 14, 26$2.08Jan 16, 26$2.16Jan 21, 26$4.03Jan 23, 26$4.11Jan 27, 26$4.57Jan 29, 26$4.64Feb 2, 26$4.56Feb 4, 26$4.71Feb 9, 26$4.55Feb 11, 26$4.54Feb 13, 26$4.57Feb 18, 26$4.55Feb 20, 26$4.48Feb 24, 26$4.40Feb 26, 26$4.41Mar 2, 26$4.38Mar 4, 26$4.31Mar 6, 26$4.18Mar 10, 26$5.03Mar 12, 26$5.03Mar 17, 26$5.03Mar 19, 26$5.02Mar 23, 26$5.02Mar 25, 26$5.01Mar 27, 26$5.02Mar 31, 26$5.01Apr 2, 26$5.02Apr 7, 26$5.00Apr 9, 26$5.00Apr 13, 26$4.99Apr 15, 26$4.01Apr 17, 26$3.23Apr 22, 26$3.42Apr 24, 26$3.20Apr 28, 26$3.20Apr 30, 26$3.12May 4, 26$3.35May 6, 26$3.26May 8, 26$3.15May 12, 26$3.26May 14, 26$3.08May 18, 26$3.12May 20, 26$3.18May 22, 26$3.14May 28, 26$3.30Jun 1, 26$3.58Jun 3, 26$3.48Jun 5, 26$3.35Jun 9, 26$3.46Jun 11, 26$3.48Jun 15, 26$3.45Jun 17, 26$3.52Jun 22, 26$3.47Jun 24, 26$3.44Jun 26, 26$3.36Jul 2, 26$3.33
$1.8652-week range$5.04
Loading valuation history…

Fundamentals

Key fundamentals

$28.8M

Market cap

—

Revenue growth (YoY)

14.1%

Gross margin

-$16M

Free cash flow (USD)

-$16M

Net debt

Net cash position

4.3%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$35.3MFY 2017$0.00FY 2018$0.00FY 2019$0.00FY 2020$0.00FY 2021$0.00FY 2022$0.00FY 2023$0.00FY 2024$1.0MFY 2025$170.0K
$35.3M$170K

Free cash flow by year

2016 → 2025

FY 2016$-26.5MFY 2017$-21.0MFY 2018$-20.1MFY 2019$-18.9MFY 2020$-8.8MFY 2021$-22.3MFY 2022$-21.5MFY 2023$-20.0MFY 2024$-19.4MFY 2025$-16.0M
-$26.5M-$16M

Gross margin by year

2024 → 2025

FY 2024100.0%FY 202514.1%
100.0%14.1%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 11, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventMerger Agreement AmendmentJun 9, 2026Filing
  • 8-K eventTender Offer UpdateJun 1, 2026Filing
  • 8-K eventMerger AgreementMay 29, 2026Filing
  • Quarterly report10-Q FiledMay 11, 2026Filing
  • 8-K eventMerger Agreement AmendmentMay 4, 2026Filing
  • Annual report10-K FiledApr 28, 2026Filing
  • 8-K eventTender Offer ExtensionApr 15, 2026Filing
  • 8-K eventTender Offer ExtensionApr 3, 2026Filing

Questions

Frequently asked questions

What is Lisata Therapeutics, Inc.'s market cap?

Lisata Therapeutics, Inc. (LSTA) has a market capitalization of $28.8M.

What is LSTA's P/E ratio?

A meaningful P/E ratio is not available for LSTA — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is LSTA's price-to-book (P/B) ratio?

LSTA trades at 1.94 times book value per share.

Are insiders buying LSTA stock?

SEC Form 4 filings show no open-market insider buys at Lisata Therapeutics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

IGC

IGC Pharma, Inc.

$28.7M

BRNS

Barinthus Biotherapeutics plc

$27.9M

DYAI

Dyadic International, Inc.

$27.9M

OTLK

Outlook Therapeutics, Inc.

$30M

IBIO

iBio, Inc.

$30.2M

TVRD

Tvardi Therapeutics, Inc.

$31.4M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.